Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves

In this retrospective comparative study, we evaluated the effectiveness of remdesivir (RDSV) in patients with SARS-CoV-2 pneumonia. Individuals hospitalized between March 2020 and August 2022 at S.M. Goretti Hospital, Latina, with a positive test for SARS-CoV-2 and, concomitantly, pneumonia, were in...

Descripción completa

Detalles Bibliográficos
Autores principales: Marocco, Raffaella, Del Borgo, Cosmo, Tortellini, Eeva, Garattini, Silvia, Carraro, Anna, Di Trento, Daniela, Gasperin, Andrea, Grimaldi, Alessandra, Tieghi, Tiziana, Belvisi, Valeria, Kertusha, Blerta, Guardiani, Mariasilvia, Zuccalà, Paola, Alunni Fegatelli, Danilo, Spagnoli, Alessandra, Lichtner, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143300/
https://www.ncbi.nlm.nih.gov/pubmed/37112927
http://dx.doi.org/10.3390/v15040947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143300/
https://www.ncbi.nlm.nih.gov/pubmed/37112927
http://dx.doi.org/10.3390/v15040947

Ejemplares similares